KalVista Pharmaceuticals (KALV) Non-Current Assets (2016 - 2024)
Historic Non-Current Assets for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $8.8 million.
- KalVista Pharmaceuticals' Non-Current Assets changed N/A to $8.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $35.7 million, marking a year-over-year change of. This contributed to the annual value of $9.7 million for FY2024, which is N/A changed from last year.
- As of Q4 2024, KalVista Pharmaceuticals' Non-Current Assets stood at $8.8 million.
- KalVista Pharmaceuticals' Non-Current Assets' 5-year high stood at $10.5 million during Q3 2023, with a 5-year trough of $3.4 million in Q4 2020.
- Its 4-year average for Non-Current Assets is $7.1 million, with a median of $8.6 million in 2024.
- Over the last 5 years, KalVista Pharmaceuticals' Non-Current Assets had its largest YoY gain of 5962.63% in 2020, and its largest YoY loss of 1917.55% in 2020.
- Quarter analysis of 4 years shows KalVista Pharmaceuticals' Non-Current Assets stood at $3.4 million in 2020, then grew by 9.79% to $3.7 million in 2021, then skyrocketed by 173.82% to $10.1 million in 2023, then decreased by 12.82% to $8.8 million in 2024.
- Its Non-Current Assets stands at $8.8 million for Q4 2024, versus $8.6 million for Q4 2024 and $8.6 million for Q3 2024.